Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

INSANE: 14 | Rare Historical Photos

Mattel introduces its first Barbie with Type 1 diabetes

Mattel has introduced its first Barbie doll with representing someone with Type 1 diabetes

The Independent UK

Why Mattel Created a Type 1 Diabetes Barbie Doll: A Focus On The Growing Health Crisis Among Young Girls

Barbie now reflects real-life conditions. Mattel releases a Type 1 diabetes doll amid rising cases among UK girls and calls for inclusive representation.

International Business Times UK

Weight loss jabs not enough to tackle obesity, leading medics warn

The Royal College of Physicians (RCP) called on the government to tackle the nation’s ‘broken food system’

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Barbie Launches First-Ever Type 1 Diabetes Doll, Honors Latina Fitness Star Robin Arzón

Mattel has unveiled the first-ever Barbie doll with Type 1 diabetes, joining its Barbie Fashionistas line in a groundbreaking move toward better representation for children managing chronic health conditions.

Latin Times

US children much more likely to die than in similar countries, study finds

The health of U.S. children has significantly deteriorated over the past 17 years, according to a new study

The Independent UK

Mother of two becomes first UK patient to receive ‘groundbreaking’ new diabetes drug

New drug offers future hope that people with type 1 diabetes will not need to take insulin

The Independent UK

Weight-loss jabs helped us when all else failed

Letters: Rebecca Nottingham says healthcare for those struggling with obesity is abysmal, while Andy Taylor says Mounjaro has been revoluntionary for him. Plus a letter from Michael E Corby

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Obesity drug prices are dropping, but getting a steady supply remains a challenge

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging

The Independent UK

Waste of time and money in hospitals makes you want to cry, NHS England chief says

It is a ‘stain on our country’ that the poorest receive some of the worst care, Dr Penny Dash says

The Independent UK

OPINION - A 'fat free' Britain by 2035? Slim chance of that

It seems fair to say this government, turning one year old this week, has not yet achieved a reputation for speedy resolution of major national crises. Yet within the new 10 Year Health Plan is a radical plan – to make Britain “fat free” by 2035.

Evening Standard

Weight-loss jabs on NHS may be rolled out ‘in high streets and shopping centres’

Health Secretary Wes Streeting said half his colleagues are taking weight-loss jabs.

Evening Standard

Restaurants could be forced to report customer calorie counts to help combat obesity

Hospitality bosses claimed they were ‘totally blindsided’ by the plans and said they would lead to increased costs

The Independent UK

Wes Streeting: ‘half my colleagues’ in Commons using weight loss drugs

Health secretary says the drugs are the ‘talk of the House of Commons tea rooms’ as he vows to widen access to jabs

The Guardian - UK

Free weight loss jabs to be easier to get on NHS under 10-year health plan, says Wes Streeting

Wes Streeting said the so called ‘fat jabs’ should be available according to need, not the ability to pay

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

UK’s obesity and overweight epidemic costs £126bn a year, study suggests

Exclusive: Experts say higher figure than past estimates should be wake-up call for ministers to tackle obesity

The Independent UK

Researchers say they have a better way to measure weight than BMI

The cost-effective option is already found in some primary care practices

The Guardian - UK

The way to tackle obesity in the UK is to make healthy food affordable. But the government won’t admit it

We can’t fix this crisis with vouchers, loyalty cards or supermarket displays. Either prices have to come down or incomes have to go up, writes Zoe Williams

The Independent UK

This 10-year plan may be the last chance to save the NHS

THE INDEPENDENT VIEW: Editorial: Universal healthcare free at the point of need is a noble idea but it desperately needs Labour’s reforms to work if it is to survive

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

After Ozempic, Women On Mounjaro May Be Overlooking A Serious Pancreas Problem

Women on Mounjaro may miss signs of pancreatitis. Learn the symptoms, risks, and what UK health authorities are doing to monitor GLP-1 weight loss drugs.

The Guardian - UK

As an NHS GP, I can now prescribe weight-loss jabs – but a quick fix for obesity is not what we need

Few patients will be eligible for the drugs. Better food regulation and social policy are far more likely to give lasting results, says GP Helen Salisbury

Evening Standard

Weight loss jabs are linked to 10 deaths caused by serious side effects, prompting new study

Data show that since the drugs were licensed there have been hundreds of cases of acute and chronic pancreatitis

The Independent UK

Weight-loss jabs linked to hundreds of cases of life-threatening illness and 10 deaths

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute and chronic pancreatitis among people taking them, figures from the UK’s medicines regulator reveal

The Guardian - UK

Hundreds of weight loss and diabetes jab users report pancreas problems

UK health officials launch study into side-effects of weight loss drugs after increased reports of acute pancreatitis

The Independent UK

‘Holy grail’ diet pill burns fat without affecting appetite or muscle mass unlike weight loss jabs

This new pill works by triggering the metabolism in the muscles, activating them to burn more fat, without the gastrointestinal side effects of weight loss jabs

The Independent UK

New once-a-month drug could treat diabetes and obesity, scientists say

Researchers say experimental drug’s less frequent dosing could improve adherence and offer long-term control

1 … 13 14 15 16

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Exeter

Karolinska Institutet

47 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.